Loading…

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

Saved in:
Bibliographic Details
Published in:BMC pharmacology 2011-08, Vol.11 (S1), p.P18-P18, Article P18
Main Authors: Costello-Boerrigter, Lisa C, Schirger, John A, Miller, Wayne L, Boerrigter, Guido, Chen, Horng H, Kempf, Ruth, Lee, Candace Y, Burnett, John C
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1471-2210
1471-2210
DOI:10.1186/1471-2210-11-S1-P18